drugset / Trial / NCT07495956
cfMSC Therapy for Diabetes
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the feasibility, safety and clinical efficacy of the novel clonal fetal mesenchymal stem cell (cfMSC) therapy in patients with type II diabetes mellitus.
Timeline
- Start
- 2026-03-16
- Primary completion
- 2029-03-31
- Completion
- 2030-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | cfMSCs | Unknown | — | Intravenous |